{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:58:08Z","timestamp":1793383088852,"version":"4.5.0"},"reference-count":103,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.autrev.2020.102612","type":"journal-article","created":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T01:44:38Z","timestamp":1594518278000},"page":"102612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Rhupus: a systematic literature review"],"prefix":"10.1016","volume":"19","author":[{"given":"Luca","family":"Antonini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Le Mauff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Marcelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achille","family":"Aouba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"de Boysson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2020.102612_bb0005","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2015-000084","article-title":"Patients with overlap autoimmune disease differ from those with \u2018pure\u2019 disease","volume":"2","author":"Lockshin","year":"2015","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.autrev.2020.102612_bb0010","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1136\/ard.2006.062984","article-title":"Development of additional autoimmune diseases in a multiethnic cohort of patients with systemic lupus erythematosus with reference to damage and mortality","volume":"66","author":"Chambers","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102612_bb0015","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1007\/s12325-017-0627-3","article-title":"Prevalence of co-existing autoimmune disease in rheumatoid arthritis: a cross-sectional study","volume":"34","author":"Simon","year":"2017","journal-title":"Adv Ther"},{"key":"10.1016\/j.autrev.2020.102612_bb0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3899\/jrheum.081067","article-title":"Overlap between systemic lupus erythematosus and rheumatoid arthritis: is it real or just an illusion?","volume":"36","author":"Amezcua-Guerra","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2020.102612_bb0025","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1001\/archinte.1936.00170140087006","article-title":"Nonbacterial thrombotic endocarditis: associated with prolonged fever, arthritis, inflammation of serous membranes and widespread vascular lesions","volume":"58","author":"Friedberg","year":"1936","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.autrev.2020.102612_bb0030","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1001\/archinte.1950.00230120009002","article-title":"Syndrome characterized by glomerulonephritis and arthritis Libman-Sacks disease with predominantly renal involvement","volume":"85","author":"Daugherty","year":"1950","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.autrev.2020.102612_bb0035","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10067-004-0951-2","article-title":"Lupus arthropathy: historical evolution from deforming arthritis to rhupus","volume":"23","author":"Fernandez","year":"2004","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102612_bb0040","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00000441-196011000-00008","article-title":"The L.E. cell in rheumatoid arthritis","volume":"240","author":"Toone","year":"1960","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.autrev.2020.102612_bb0045","first-page":"1","article-title":"Coexistence of rheumatoid arthritis and systemic lupus erythematosus is still rare in the biologic era: report of seven cases and literature review","author":"Kondo","year":"2019","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2020.102612_bb0050","first-page":"14","article-title":"Safety and efficacy of etanercept-methotrexate combination therapy in patients with rhupus: an observational study of non-glucocorticoid treatment for rheumatic diseases","volume":"25","author":"Yang","year":"2018","journal-title":"Discov Med"},{"key":"10.1016\/j.autrev.2020.102612_bb0055","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1177\/0961203318793715","article-title":"An imbalance in the T-helper phenotypes displayed by senescent CD4(+)CD28(null) T cells is associated with erosive arthritis (rhupus syndrome) in systemic lupus erythematosus","volume":"27","author":"Lozada-Navarro","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2020.102612_bb0060","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2017-000555","article-title":"Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patients","volume":"3","author":"Danion","year":"2017","journal-title":"RMD Open"},{"key":"10.1016\/j.autrev.2020.102612_bb0065","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10067-015-3127-3","article-title":"Chronic arthritis in systemic lupus erythematosus: distinct features in 336 paediatric and 1830 adult patients","volume":"35","author":"Gormezano","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102612_bb0070","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s13075-016-1125-8","article-title":"Ultrasonographic assessment of bone erosions in the different subtypes of systemic lupus erythematosus arthritis: comparison with computed tomography","volume":"18","author":"Piga","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2020.102612_bb0075","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000049","article-title":"Clinical analysis of 56 patients with rhupus syndrome: manifestations and comparisons with systemic lupus erythematosus: a retrospective case-control study","volume":"93","author":"Li","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2020.102612_bb0080","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1177\/0961203314526439","article-title":"Clinical and laboratory profiles of rhupus syndrome in a Chinese population: a single-centre study of 51 patients","volume":"23","author":"Liu","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2020.102612_bb0085","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.autrev.2012.09.004","article-title":"Rhupus syndrome: assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients","volume":"12","author":"Tani","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102612_bb0090","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.reuma.2012.10.010","article-title":"Efficacy and tolerability of rituximab in patients with rhupus","volume":"9","author":"Andrade-Ortega","year":"2013","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.autrev.2020.102612_bb0095","doi-asserted-by":"crossref","first-page":"697525","DOI":"10.1155\/2013\/697525","article-title":"Efficacy of abatacept for arthritis in patients with an overlap syndrome between rheumatoid arthritis and systemic lupus erythematosus","volume":"2013","author":"Ikeda","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.autrev.2020.102612_bb0100","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/0961203313482741","article-title":"Rituximab treatment for \u2018rhupus syndrome\u2019: clinical and power-Doppler ultrasonographic monitoring of response. A longitudinal pilot study","volume":"22","author":"Piga","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2020.102612_bb0105","first-page":"475","article-title":"Rhupus: when rheumatoid arthritis meets lupus","volume":"67","author":"Malaise","year":"2012","journal-title":"Rev Med Liege"},{"key":"10.1016\/j.autrev.2020.102612_bb0110","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.reuma.2010.12.006","article-title":"Rhupus: report of 4 cases","volume":"7","author":"Benavente","year":"2011","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.autrev.2020.102612_bb0115","first-page":"77","article-title":"Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus","volume":"35","author":"Chan","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2020.102612_bb0120","first-page":"47","article-title":"Erosive arthropathy: clinical variance in lupus erythematosus and association with anti-CCP case series and review of the literature","volume":"25","author":"Martinez","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2020.102612_bb0125","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s10067-005-1149-y","article-title":"Lupus arthropathy: a case series of patients with rhupus","volume":"25","author":"Fern\u00e1ndez","year":"2006","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102612_bb0130","doi-asserted-by":"crossref","first-page":"R144","DOI":"10.1186\/ar2036","article-title":"Presence of antibodies against cyclic citrullinated peptides in patients with \u201crhupus\u201d: a cross-sectional study","volume":"8","author":"Amezcua-Guerra","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2020.102612_bb0135","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/08916930500050145","article-title":"Overlap syndromes in the context of shared autoimmunity","volume":"38","author":"Rodr\u00edguez-Reyna","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2020.102612_bb0140","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1191\/0961203302lu189oa","article-title":"Clinical and immunogenetic characterization of Mexican patients with \u2018rhupus\u2019","volume":"11","author":"Sim\u00f3n","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2020.102612_bb0145","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/ard.51.2.173","article-title":"Coexistent rheumatoid arthritis and systemic lupus erythematosus: clinical, serological, and phenotypic features","volume":"51","author":"Brand","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102612_bb0150","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/ard.46.11.853","article-title":"Concurrence of rheumatoid arthritis and systemic lupus erythematosus: report of 11 cases","volume":"46","author":"Cohen","year":"1987","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102612_bb0155","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.autrev.2005.09.005","article-title":"The different faces of shared autoimmunity","volume":"5","author":"Rodriguez-Reyna","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102612_bb0160","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3899\/jrheum.080091","article-title":"Systemic lupus erythematosus features in rheumatoid arthritis and their effect on overall mortality","volume":"36","author":"Icen","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2020.102612_bb0165","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/0961203315604910","article-title":"Circulating CD4+CD28null and extra-thymic CD4+CD8+ double positive T cells are independently associated with disease damage in systemic lupus erythematosus patients","volume":"25","author":"Ugarte-Gil","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2020.102612_bb0170","first-page":"1008","article-title":"Peripheral CD4+CD28null T-cells as predictors of damage in systemic lupus erythematosus patients","volume":"36","author":"Ugarte-Gil","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2020.102612_bb0175","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/1756-185X.12056","article-title":"Reduced numbers of circulating CD28-negative CD4+ cells in patients with rheumatoid arthritis chronically treated with abatacept","volume":"16","author":"Gomez-Garcia","year":"2013","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102612_bb0180","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/BOR.0000000000000011","article-title":"T-cell aging in rheumatoid arthritis","volume":"26","author":"Weyand","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102612_bb0185","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/ard.2010.137174","article-title":"Study of the common genetic background for rheumatoid arthritis and systemic lupus erythematosus","volume":"70","author":"Orozco","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102612_bb0190","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1086\/319518","article-title":"A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases","volume":"68","author":"Jawaheer","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.autrev.2020.102612_bb0195","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/annrheumdis-2016-209436","article-title":"A combined large-scale meta-analysis identifies COG6 as a novel shared risk locus for rheumatoid arthritis and systemic lupus erythematosus","volume":"76","author":"Marquez","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102612_bb0200","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1136\/ard.2011.150326","article-title":"Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway","volume":"70","author":"Higgs","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102612_bb0205","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1741-7015-11-73","article-title":"How do autoimmune diseases cluster in families? A systematic review and meta-analysis","volume":"11","author":"Cardenas-Roldan","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.autrev.2020.102612_bb0210","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/art.21739","article-title":"The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis","volume":"54","author":"van der Helm-van Mil","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102612_bb0215","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/rheumatology\/keh686","article-title":"The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis","volume":"44","author":"Korendowych","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2020.102612_bb0220","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1002\/art.21385","article-title":"Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins","volume":"52","author":"Huizinga","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102612_bb0225","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.reprotox.2006.04.001","article-title":"Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases","volume":"22","author":"Doria","year":"2006","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.autrev.2020.102612_bb0230","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/1529-0131(200005)43:5<1010::AID-ANR8>3.0.CO;2-O","article-title":"Breast-feeding and postpartum relapse in women with rheumatoid and inflammatory arthritis","volume":"43","author":"Barrett","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102612_bb0235","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/art.1780350205","article-title":"Timing of pregnancy in relation to the onset of rheumatoid arthritis","volume":"35","author":"Silman","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102612_bb0240","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/ard.2009.115964","article-title":"Postpartum onset of rheumatoid arthritis and other chronic arthritides: results from a patient register linked to a medical birth registry","volume":"69","author":"Wallenius","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102612_bb0245","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00124743-199902000-00002","article-title":"Influence of hormonal events on disease expression in patients with the combination of systemic lupus erythematosus and rheumatoid arthritis","volume":"5","author":"Sundaramurthy","year":"1999","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102612_bb0250","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ejim.2008.01.017","article-title":"Deforming arthropathy in systemic lupus erythematosus","volume":"19","author":"Pipili","year":"2008","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.autrev.2020.102612_bb0255","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/ard.51.3.358","article-title":"Patients with systemic lupus erythematosus and Jaccoud\u2019s arthropathy: a clinical subset with an increased C reactive protein response?","volume":"51","author":"Spronk","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102612_bb0260","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.semarthrit.2017.03.022","article-title":"Joint involvement in systemic lupus erythematosus: from pathogenesis to clinical assessment","volume":"47","author":"Ceccarelli","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102612_bb0265","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1093\/rheumatology\/kes226","article-title":"Joint and tendon involvement in systemic lupus erythematosus: an ultrasound study of hands and wrists in 108 patients","volume":"51","author":"Gabba","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2020.102612_bb0270","first-page":"708","article-title":"Successful treatment using cyclosporine in a patient with rhupus complicated by aplastic anemia: a case report and review of the literature","volume":"29","author":"Seo","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2020.102612_bb0275","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00296-009-1007-3","article-title":"Diffuse lupus encephalopathy in a case of rhupus syndrome","volume":"30","author":"Wang","year":"2010","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2020.102612_bb0280","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/0049475519854623","article-title":"Libman-sacks endocarditis in a bangladeshi patient suffering from rhupus","volume":"49","author":"Zaman","year":"2019","journal-title":"Trop Doct"},{"key":"10.1016\/j.autrev.2020.102612_bb0285","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.reuma.2017.02.007","article-title":"Rhupus and autoimmune hepatitis: a rare association","volume":"13","author":"Zavala-Flores","year":"2017","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.autrev.2020.102612_bb0290","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4081\/reumatismo.2015.858","article-title":"Systemic vasculitis in a patient with rhupus syndrome","volume":"67","author":"Zengin","year":"2015","journal-title":"Reumatismo"},{"key":"10.1016\/j.autrev.2020.102612_bb0295","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1526-4610.2007.00981.x","article-title":"Headache in a case of rhupus syndrome","volume":"48","author":"Chowdhury","year":"2008","journal-title":"Headache"},{"key":"10.1016\/j.autrev.2020.102612_bb0300","doi-asserted-by":"crossref","first-page":"390","DOI":"10.4103\/0970-2113.142133","article-title":"Bilateral pleural effusion with APLA positivity in a case of rhupus syndrome","volume":"31","author":"Saha","year":"2014","journal-title":"Lung India"},{"key":"10.1016\/j.autrev.2020.102612_bb0305","first-page":"OD05","article-title":"A rare case of mixed connective tissue disease (MCTD) with intricate features of lupus, polymyositis and rheumatoid arthritis presenting with severe myositis","volume":"9","author":"Lokesh","year":"2015","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.autrev.2020.102612_bb0310","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.06.2009.1967","article-title":"Analgesics are not always the culprits: isolated gastric fundal varices as the cause of recurrent upper GI bleed in a patient with SLE, rheumatoid arthritis and polymyositis overlap syndrome","volume":"2009","author":"Wani","year":"2009","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.autrev.2020.102612_bb0315","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00296-005-0084-1","article-title":"A case of overlap syndrome with rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis and secondary Sjogren\u2019s syndrome","volume":"26","author":"Turkcapar","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2020.102612_bb0320","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00011-008-8110-x","article-title":"Erosive arthritis in systemic lupus erythematosus is associated with high serum C-reactive protein and anti-cyclic citrullinated peptide antibodies","volume":"57","author":"Amezcua-Guerra","year":"2008","journal-title":"Inflamm Res"},{"key":"10.1016\/j.autrev.2020.102612_bb0325","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4081\/reumatismo.2012.321","article-title":"Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease?","volume":"64","author":"Taraborelli","year":"2012","journal-title":"Reumatismo"},{"key":"10.1016\/j.autrev.2020.102612_bb0330","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1177\/0961203318759607","article-title":"The lupus patient with positive rheumatoid factor","volume":"27","author":"Fedrigo","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2020.102612_bb0335","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s002960050112","article-title":"Rheumatoid factors in systemic lupus erythematosus: association with clinical and laboratory parameters. SLE study group","volume":"19","author":"Witte","year":"2000","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2020.102612_bb0340","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jbspin.2008.11.007","article-title":"What can we learn from the presence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus?","volume":"76","author":"Zhao","year":"2009","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2020.102612_bb0345","first-page":"179","article-title":"The significance of rheumatoid factor and anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus","volume":"51","author":"Popescu","year":"2013","journal-title":"Rom J Intern Med"},{"key":"10.1016\/j.autrev.2020.102612_bb0350","doi-asserted-by":"crossref","first-page":"97","DOI":"10.22631\/rr.2017.69997.1025","article-title":"Role of anti-CCP in arthritis in patients with systemic lupus erythematosus","volume":"2","author":"Faezi","year":"2017","journal-title":"Rheumatol Res"},{"key":"10.1016\/j.autrev.2020.102612_bb0355","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s13075-016-1192-x","article-title":"Antibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohorts","volume":"18","author":"Ziegelasch","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2020.102612_bb0360","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/0961203307087613","article-title":"Anti-citrullinated peptide antibodies in lupus patients with or without deforming arthropathy","volume":"17","author":"Damian-Abrego","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2020.102612_bb0365","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1002\/art.23763","article-title":"Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease","volume":"58","author":"Ioan-Facsinay","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102612_bb0370","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-146-11-200706050-00008","article-title":"Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis","volume":"146","author":"Nishimura","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2020.102612_bb0375","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.autrev.2009.11.017","article-title":"Profiling of rheumatoid arthritis associated autoantibodies","volume":"9","author":"Conrad","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102612_bb0380","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00296-010-1374-9","article-title":"Anticyclic citrullinated peptide autoantibodies in systemic lupus erythematosus","volume":"31","author":"Singh","year":"2011","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2020.102612_bb0385","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.3899\/jrheum.090338","article-title":"Citrulline dependence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus as a marker of deforming\/erosive arthritis","volume":"36","author":"Kakumanu","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2020.102612_bb0390","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1177\/0961203309102817","article-title":"The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus","volume":"18","author":"Qing","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2020.102612_bb0395","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.autrev.2015.01.013","article-title":"Citrullination and autoimmunity","volume":"14","author":"Valesini","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102612_bb0400","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1177\/0961203314540967","article-title":"Anti-cyclic citrullinated peptide antibody as a marker of erosive arthritis in patients with systemic lupus erythematosus: a systematic review and meta-analysis","volume":"23","author":"Budhram","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2020.102612_bb0405","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/ard.60.1.67","article-title":"Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"60","author":"Mediwake","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102612_bb0410","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/rheumatology\/keu215","article-title":"A study of erosive phenotypes in lupus arthritis using magnetic resonance imaging and anti-citrullinated protein antibody, anti-RA33 and RF autoantibody status","volume":"53","author":"Ball","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2020.102612_bb0415","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1177\/0961203315570165","article-title":"Anti-CCP antibodies as a marker of rhupus","volume":"24","author":"Amaya-Amaya","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2020.102612_bb0420","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13075-018-1622-z","article-title":"Anti-carbamylated protein antibodies as a new biomarker of erosive joint damage in systemic lupus erythematosus","volume":"20","author":"Ceccarelli","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2020.102612_bb0425","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/0961203317713141","article-title":"Anti-carbamylated protein antibodies in systemic lupus erythematosus patients with articular involvement","volume":"27","author":"Massaro","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2020.102612_bb0430","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4078\/jrd.2018.25.2.144","article-title":"Patient with systemic lupus erythematosus combined with erosive arthritis was treated successfully with tocilizumab: a case report","volume":"25","author":"Kim","year":"2018","journal-title":"J Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102612_bb0435","article-title":"Belimumab treatment in rhupus: a case report with severe skin involvement","volume":"32","author":"Dayer","year":"2019","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.autrev.2020.102612_bb0440","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.autrev.2017.04.011","article-title":"International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus","volume":"16","author":"Kleinmann","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102612_bb0445","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MD.0b013e3181441a68","article-title":"Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases","volume":"86","author":"Ramos-Casals","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2020.102612_bb0450","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1002\/art.20576","article-title":"Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study","volume":"50","author":"Aringer","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102612_bb0455","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1177\/0961203309102557","article-title":"Efficacy and safety of infliximab in active SLE: a pilot study","volume":"18","author":"Uppal","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2020.102612_bb0460","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1002\/art.27601","article-title":"The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial","volume":"62","author":"Merrill","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102612_bb0465","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/art.38260","article-title":"Efficacy and safety of abatacept in lupus nephritis: a twelve-month, randomized, double-blind study","volume":"66","author":"Furie","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2020.102612_bb0470","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.autrev.2012.06.004","article-title":"Overlap connective tissue disease syndromes","volume":"12","author":"Iaccarino","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102612_bb0475","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/art.27233","article-title":"Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase ii\/iii systemic lupus erythematosus evaluation of rituximab trial","volume":"62","author":"Merrill","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102612_bb0480","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/art.34359","article-title":"Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study","volume":"64","author":"Rovin","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102612_bb0485","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/rheumatology\/kex395","article-title":"Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register","volume":"57","author":"McCarthy","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2020.102612_bb0490","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1002\/art.27541","article-title":"Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry","volume":"62","author":"Terrier","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102612_bb0495","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1177\/0961203315627199","article-title":"The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort","volume":"25","author":"Conti","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2020.102612_bb0500","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/rheumatology\/ker381","article-title":"Lupus arthritis--do we have a clinically useful classification?","volume":"51","author":"Ball","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2020.102612_bb0505","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/rheumatology\/kes138","article-title":"Comment on: lupus arthritis--do we have a clinically useful classification?","volume":"51","author":"Amezcua-Guerra","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2020.102612_bb0510","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/RHU.0b013e31815bfe14","article-title":"Revisiting jaccoud arthropathy as an ultrasound diagnosed erosive arthropathy in systemic lupus erythematosus","volume":"13","author":"Saketkoo","year":"2007","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102612_bb0515","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/ard.57.9.540","article-title":"Deforming arthropathy or lupus and rhupus hands in systemic lupus erythematosus","volume":"57","author":"van Vugt","year":"1998","journal-title":"Ann Rheum Dis"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220301798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220301798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:18:29Z","timestamp":1761599909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997220301798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":103,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1568997220301798"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102612","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rhupus: a systematic literature review","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102612","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102612"}}